Manganese and Developmental Neurotoxicity

Roberto Lucchini1,2, Donatella Placidi3, Giuseppa Cagna3

  • 1Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. roberto.lucchini@mssm.edu.

Advances in Neurobiology
|September 11, 2017
PubMed

Insights

Environmental manganese (Mn) exposure can harm brain development, especially in children, potentially causing Parkinson-like symptoms and affecting cognitive functions. Research is exploring sources and biomarkers for prevention strategies.

Area of Science:

  • Neuroscience
  • Environmental Health
  • Toxicology

Background:

  • Manganese (Mn) is vital for brain function but environmental overexposure can lead to neurotoxicity.
  • Accumulation in the basal ganglia is linked to Parkinson-like disorders.
  • Early-life exposure is a growing concern, potentially impacting cognitive and executive functions via the frontal cortex.

Purpose of the Study:

  • To review environmental sources of manganese exposure.
  • To explore mechanisms of developmental neurotoxicity.
  • To identify biomarkers for early detection of exposure and functional alterations.

Main Methods:

  • Literature review of environmental manganese exposure.
  • Analysis of neurotoxicity mechanisms in developmental stages.
  • Examination of biomarkers for manganese-related neurodevelopmental issues.

Main Results:

  • Environmental manganese exposure poses risks to brain development, particularly in early life.
  • Overexposure can lead to Parkinson-like symptoms and affect cognitive functions.
  • Identifying exposure sources and biomarkers is crucial for prevention.

Conclusions:

  • Understanding developmental neurotoxicity of manganese is essential for public health.
  • Preventive strategies require knowledge of environmental sources and early biomarkers.
  • Further research is needed to mitigate risks associated with environmental manganese exposure.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38